Top in endocrinology: Thyroid cancer burden; PFAS exposure and diabetes risk
Click Here to Manage Email Alerts
Researchers examining global trends in thyroid cancer found an increased incidence over a 30-year period, including in the U.S. and Europe. It was the top story in endocrinology last week.
The second top story was about a link between high levels of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and an increased risk for diabetes in middle-aged women. Researchers said the findings reveal the need for policy changes to lower the number of products with PFAS.
Read these and more top stories in endocrinology below:
Thyroid cancer burden on rise in US, Europe
A new study has found an increase in thyroid cancer incidence rates over a 30-year period in many countries, including the United States and several countries in the European Union. Read more.
Greater exposure to PFAS endocrine-disrupting chemicals increases diabetes risk for women
Middle-aged women exposed to higher levels of the endocrine-disrupting chemical class of PFAS have an increased risk for developing diabetes, according to study data. Read more.
Glycemia Risk Index provides new tool for assessing glycemic control with CGM data
A new metric could help simplify continuous glucose monitoring data for people with diabetes and furnish actionable analysis for providers. Read more.
Healthy plant-based diet linked to lower risk for type 2 diabetes
Metabolite profiles demonstrate that eating a healthy plant-based diet rich in whole grains, fruits, vegetables and nuts can lower one’s risk for developing type 2 diabetes, according to study findings published in Diabetologia. Read more.
Lower birth weight tied to type 2 diabetes at younger age, lower BMI
Having a lower birth weight is associated with type 2 diabetes onset at a younger age, and those with a lower birth weight are also more likely to have a lower BMI at diagnosis, according to study findings published in Diabetic Medicine. Read more.